BriaCell develops ovarian cancer immunotherapy candidate
Go back to BriaCell develops ovarian cancer immunotherapy candidate| (NASDAQ: BCTX) | Delayed: 2.90 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.90 | 52 Week High | $ | |||
| Open | $2.90 | 52 Week Low | $ | |||
| Day High | $2.90 | P/E | N/A | |||
| Day Low | $2.90 | EPS | $ | |||
| Volume | 104 | |||||

